Cerenis Therapeutics' Series C Round

Cerenis Therapeutics raised a round of funding on July 25, 2010.

Cerenis Therapeutics is a biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases. Cereni…

Articles about Cerenis Therapeutics' Series C Round: